Repaglinide (Prandin) side effects
The most commonly reported side effect of Repaglinide is hypoglycemia. If a patient becomes hypoglycemic during therapy, aggressive treatment with oral glucose and subsequent monitoring by a clinician is recommended.
This medication is generally well-tolerated. The most common secondary side effects are gastrointestinal. There was a small but clinically significant increase in serious cardiovascular events for those taking Prandin relative to control patients.
Although it is rare you may experience negative effects as a result of using this medication.
Common side effects include the following:
- Blurred vision
- Dizziness
- Runny nose
- Joint pain
- Headache
- Diarrhea
- Back pain
Repaglinide may also lead to serious side effects. In case you experience any of the following negative effects, you should call your doctor immediately.
Serious side effects include:
- Seizure
- Sore throat
- Red skin rash
- Nausea
- Vomiting
- Fever
- Confusion
- Weakness
—
Disclaimer: Please note that the contents of this community article are strictly for informational purposes and should not be considered as medical advice. This article, and other community articles, are not written or reviewed for medical validity by Canadian Insulin or its staff. All views and opinions expressed by the contributing authors are not endorsed by Canadian Insulin. Always consult a medical professional for medical advice, diagnosis, and treatment.
